In-patient outcomes of Hematopoietic Stem Cell Transplantation in Patients with Immune Mediated Inflammatory Diseases: A Nationwide Study

The impact of underlying immune-mediated inflammatory diseases (IMID) in patients undergoing hematopoietic stem cell transplant (HSCT) is unclear. Hematopoietic cell transplantation co-morbidity index (HCT-CI) is gaining acceptance as a reliable clinical method to score pre-transplant co-morbidities...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Kathan, Jaiswal, Palashkumar, Briggs, Farren, Faubion, William A., Tabibian, James H., Cominelli, Fabio, Dave, Maneesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931606/
https://www.ncbi.nlm.nih.gov/pubmed/29717163
http://dx.doi.org/10.1038/s41598-018-24060-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931606/
https://www.ncbi.nlm.nih.gov/pubmed/29717163
http://dx.doi.org/10.1038/s41598-018-24060-4

Ejemplares similares